Format

Send to

Choose Destination
World J Nucl Med. 2019 Apr-Jun;18(2):198-200. doi: 10.4103/wjnm.WJNM_67_18.

Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity.

Author information

1
Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
2
Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
3
Department of General Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Abstract

Parathyroid carcinoma (PTC) is a rare endocrine tumor and uncommon cause for primary hyperparathyroidism. 18F-fluorocholine (FCH) positron emission tomography and computed tomography (PET/CT) has shown promising results in the detection of parathyroid adenoma, though its role in PTC is undefined due to the paucity of incidence. The authors in this case report discuss the possible complimentary role of FCH PET/CT with 18F-fluorodeoxyglucose PET/CT in the evaluation of the management of suspected recurrence, since this rare entity has high loco-regional and distant recurrence of the disease.

KEYWORDS:

18F-fluorocholine; 18F-fluorodeoxyglucose; positron emission tomography and computed tomography; recurrent parathyroid carcinoma

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center